Form 4: Aflac Director Georgette Kiser Receives Stock Grant
Statement of Changes in Beneficial Ownership
Director Georgette D. Kiser acquired 1,721 shares of Aflac Incorporated common stock via an equity incentive plan grant.
Summary
- Director Georgette D. Kiser was granted 1,721 shares of Aflac Incorporated (AFL) common stock.
- The transaction occurred on May 4, 2026.
- The shares were granted under the Aflac Incorporated Long-Term Incentive Plan.
- Following this transaction, the director's total beneficial ownership is 21,022 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.
Positives
- Director alignment with shareholder interests is reinforced through the receipt of equity compensation.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
Not applicable as this is a routine disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that routine equity grants to board members are standard corporate governance practices designed to align director incentives with long-term shareholder value creation.
Comparison to Industry Standards
- The grant is consistent with standard executive and director compensation practices in the insurance and financial services sector.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity grant.
Next Steps
- None.
Key Dates
| Date | Description |
|---|---|
| 05/04/2026 | Date of the equity grant transaction. |
| 05/06/2026 | Date the Form 4 was signed and filed. |
Keywords
Aflac, AFL, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.